Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RaySearch Laboratories AB ( ($SE:RAY.B) ) just unveiled an update.
RaySearch Laboratories has announced that it will publish its 2025 year-end report on February 12, 2026, followed by an English-language webcast presentation and Q&A led by founder and CEO Johan Löf and CFO Nina Grönberg. The event, aimed at investors and other stakeholders, will provide detailed commentary on the company’s performance and will be supported by presentation materials, the full report, and a recording made available on RaySearch’s website, underscoring the company’s focus on transparency and active communication with the capital market.
The most recent analyst rating on ($SE:RAY.B) stock is a Buy with a SEK228.00 price target. To see the full list of analyst forecasts on RaySearch Laboratories AB stock, see the SE:RAY.B Stock Forecast page.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Swedish medical technology company specializing in advanced software for cancer treatment, including the RayStation treatment planning system, the RayCare oncology information system, the RayIntelligence oncology analytics platform, and the RayCommand treatment control system. Its solutions are used by nearly 1,200 clinics in 51 countries, and the company, a spin-off from the Karolinska Institute founded in 2000, has been listed on Nasdaq Stockholm since 2003.
Average Trading Volume: 143,392
Technical Sentiment Signal: Buy
Current Market Cap: SEK7.53B
For detailed information about RAY.B stock, go to TipRanks’ Stock Analysis page.